MedTrace Logo

Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema

NCT00994799 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2009-10-16

No results posted yet for this study

Summary

This study investigates the hypothesis that ranibizumab injection given into the eye is an efficacious and safe treatment option applied for swelling of the macula (site of sharp vision) in diabetes.

Conditions

  • Macular Edema

Interventions

DRUG

ranibizumab

10mg/ml intravitreal injection

RADIATION

macular grid-pattern laser

macular grid-pattern laser therapy

Sponsors & Collaborators

  • Semmelweis University

    collaborator OTHER

  • Csolnoky Ferenc County Hospital

    collaborator UNKNOWN

  • Szeged University

    lead OTHER

Principal Investigators

  • Lajos Kolozsvari, prof · Szeged University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Completion
2011-02-28

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00994799 on ClinicalTrials.gov